SELLAS Life Sciences Group (SLS) Cash & Current Investments: 2011-2023
Historic Cash & Current Investments for SELLAS Life Sciences Group (SLS) over the last 7 years, with Dec 2023 value amounting to $2.5 million.
- SELLAS Life Sciences Group's Cash & Current Investments rose 425.77% to $21.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $51.1 million, marking a year-over-year decrease of 13.11%. This contributed to the annual value of $2.5 million for FY2023, which is 85.23% down from last year.
- According to the latest figures from FY2023, SELLAS Life Sciences Group's Cash & Current Investments is $2.5 million, which was down 85.23% from $17.1 million recorded in FY2022.
- In the past 5 years, SELLAS Life Sciences Group's Cash & Current Investments ranged from a high of $35.3 million in FY2020 and a low of $2.5 million during FY2023.
- Moreover, its 3-year median value for Cash & Current Investments was $17.1 million (2022), whereas its average is $13.7 million.
- Its Cash & Current Investments has fluctuated over the past 5 years, first skyrocketed by 385.12% in 2020, then slumped by 85.23% in 2023.
- Yearly analysis of 5 years shows SELLAS Life Sciences Group's Cash & Current Investments stood at $7.3 million in 2019, then surged by 385.12% to $35.3 million in 2020, then plummeted by 39.51% to $21.4 million in 2021, then decreased by 19.81% to $17.1 million in 2022, then crashed by 85.23% to $2.5 million in 2023.